[HTML][HTML] Curcumin: modulator of key molecular signaling pathways in hormone-independent breast cancer

R Farghadani, R Naidu - Cancers, 2021 - mdpi.com
Simple Summary Breast cancer remains the most commonly diagnosed cancer and the
leading cause of cancer death among females worldwide. It is a highly heterogeneous …

[HTML][HTML] Circular RNAs: new layer of complexity evading breast cancer heterogeneity

A Dawoud, ZI Zakaria, HH Rashwan… - Non-Coding RNA …, 2023 - Elsevier
Advances in high-throughput sequencing techniques and bioinformatic analysis have
refuted the “junk” RNA hypothesis that was claimed against non-coding RNAs (ncRNAs) …

[HTML][HTML] Metabolic therapy and bioenergetic analysis: The missing piece of the puzzle

T Duraj, J Carrión-Navarro, TN Seyfried… - Molecular …, 2021 - Elsevier
Background Aberrant metabolism is recognized as a hallmark of cancer, a pillar necessary
for cellular proliferation. Regarding bioenergetics (ATP generation), most cancers display a …

[HTML][HTML] A systematic review of PET textural analysis and radiomics in cancer

M Piñeiro-Fiel, A Moscoso, V Pubul, Á Ruibal… - Diagnostics, 2021 - mdpi.com
Background: Although many works have supported the utility of PET radiomics, several
authors have raised concerns over the robustness and replicability of the results. This study …

[HTML][HTML] The multifaceted role of baicalein in cancer management through modulation of cell signalling pathways

AH Rahmani, A Almatroudi, AA Khan, AY Babiker… - Molecules, 2022 - mdpi.com
The roles of medicinal plants or their purified bioactive compounds have attracted attention
in the field of health sciences due to their low toxicity and minimal side effects. Baicalein is …

[HTML][HTML] Competitive endogenous role of the LINC00511/miR-185-3p axis and miR-301a-3p from liquid biopsy as molecular markers for breast cancer diagnosis

MM Mahmoud, EF Sanad, RAA Elshimy… - Frontiers in …, 2021 - frontiersin.org
Breast cancer (BC) is the leading cause of female cancer-related mortalities. Evidence has
illustrated the role of long non-coding RNAs (lncRNA) and microRNAs (miRNA) as …

[HTML][HTML] Dynamic cancer cell heterogeneity: Diagnostic and therapeutic implications

V Jacquemin, M Antoine, G Dom, V Detours… - Cancers, 2022 - mdpi.com
Simple Summary Cancer heterogeneity, which occurs in most cancer patients, has been
known and studied by experienced pathologists since the early 19th century. Intratumoral …

Identification of autophagy‐related long non‐coding RNA prognostic signature for breast cancer

Q Wu, Q Li, W Zhu, X Zhang, H Li - Journal of cellular and …, 2021 - Wiley Online Library
Autophagy‐related long non‐coding RNAs (lncRNAs) disorders are related to the
occurrence and development of breast cancer. The purpose of this study is to explore …

[HTML][HTML] LncRNA TDRKH-AS1 promotes breast cancer progression via the miR-134-5p/CREB1 axis

Y Ding, Y Huang, F Zhang, L Gong, C Liang… - Journal of Translational …, 2023 - Springer
Background Breast cancer (BC) is a prevalent malignancy with complex etiology and varied
clinical behavior. Long non-coding RNAs (lncRNAs) have emerged as key regulators in …

Mini review: The FDA-approved prescription drugs that target the MAPK signaling pathway in women with breast cancer

F Khojasteh Poor, M Keivan, M Ramazii… - Breast …, 2021 - content.iospress.com
Breast cancer (BC) is the most common cancer and the prevalent type of malignancy among
women. Multiple risk factors, including genetic changes, biological age, dense breast tissue …